Invivyd (IVVD) Non-Current Assets (2021 - 2025)

Invivyd (IVVD) posted Non-Current Assets of $29.4 million for Q4 2025, little changed on a QoQ basis from $29.4 million in Q3 2025, and up 2.02% year-over-year from $28.8 million in Q4 2024.

Invivyd (IVVD) Non-Current Assets (2021 - 2025) Analysis & Trends

Invivyd's Non-Current Assets history runs 5 years deep, the most recent figure standing at $29.4 million for Q4 2025.

  • Quarterly Non-Current Assets rose 2.02% year-over-year to $29.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $116.6 million (up 135.16% YoY) and the FY2025 annual result came in at $29.4 million, up 2.02% from the prior year.
  • Non-Current Assets was $29.4 million for Q4 2025 at Invivyd, roughly flat from $29.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $29.9 million in Q2 2025 and bottomed at $1.9 million in Q2 2021.
  • A 5-year average of $11.2 million and a median of $5.6 million in 2024 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Non-Current Assets tumbled 48.47% — and 2025, when it jumped 588.74%.
  • Invivyd's Non-Current Assets stood at $3.4 million in 2021, then jumped by 84.91% to $6.2 million in 2022, then tumbled by 31.2% to $4.3 million in 2023, then soared by 570.56% to $28.8 million in 2024, then grew by 2.02% to $29.4 million in 2025.
  • Business Quant data shows IVVD's Non-Current Assets at $29.4 million in Q4 2025, $29.4 million in Q3 2025, and $29.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 21.65 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.83 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 30.30 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.95 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - 289.41 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 285.82 Mn
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn 29.42 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 29.42 Mn
Sep 30, 2025 29.39 Mn
Jun 30, 2025 29.86 Mn
Mar 31, 2025 27.92 Mn
Dec 31, 2024 28.83 Mn
Sep 30, 2024 10.82 Mn
Jun 30, 2024 4.34 Mn
Mar 31, 2024 5.59 Mn
Dec 31, 2023 4.30 Mn
Sep 30, 2023 4.81 Mn
Jun 30, 2023 5.43 Mn
Mar 31, 2023 5.94 Mn
Dec 31, 2022 6.25 Mn
Sep 30, 2022 3.15 Mn
Jun 30, 2022 3.25 Mn
Mar 31, 2022 1.97 Mn
Dec 31, 2021 3.38 Mn
Sep 30, 2021 6.12 Mn
Jun 30, 2021 1.93 Mn